New Drug Approvals Archive

Get news by email or subscribe to our news feeds.

October 2002

October 16

Pegasys (peginterferon alfa-2a) Injection

Date of Approval: October 16, 2002
Company: Hoffmann-La Roche
Treatment for: Chronic Hepatitis C

Pegasys (peginterferon alfa-2a) is a covalent conjugate of recombinant alfa-2a interferon indicated for the combination treatment of adults with chronic hepatitis C.

August 31

Suboxone (buprenorphine and naloxone)

New Formulation Approved: August 31, 2010

August 20

Suboxone (buprenorphine and naloxone)

New Formulation Approved: August 10, 2012

Hide
(web2)